2 May 2023AmericasLiz Hockley

Judge: 3M should win COVID-19 price-gouging lawsuit

Judge enters default judgment as New Jersey-based firm failed to respond to suit | Defendant allegedly sought to sell 3M-branded masks at inflated prices during the pandemic.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

3M price-gouging case ‘crumbles like cookie’, says accused company

12 May 2020 A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit.

3M ramps up US mask litigation, secures injunction

5 May 2020 3M has filed four more trademark lawsuits against companies accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic, while also securing a preliminary injunction in another suit.

More on this story

3M ramps up US mask litigation, secures injunction

5 May 2020 3M has filed four more trademark lawsuits against companies accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic, while also securing a preliminary injunction in another suit.

3M price-gouging case ‘crumbles like cookie’, says accused company

12 May 2020 A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit.

More on this story

3M ramps up US mask litigation, secures injunction

5 May 2020 3M has filed four more trademark lawsuits against companies accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic, while also securing a preliminary injunction in another suit.

3M price-gouging case ‘crumbles like cookie’, says accused company

12 May 2020 A trademark infringement complaint filed by 3M is “short on ultimate facts and long on inflammatory, derogatory, and conclusory assertions”, according to the company accused of price-gouging in the suit.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York